Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle

Gang Wang, Anup K. Biswas, Wanchao Ma, Manoj Kandpal, Courtney Coker, Paul M. Grandgenett, Michael A Hollingsworth, Rinku Jain, Kurenai Tanji, Sara López-Pintado, Alain Borczuk, Doreen Hebert, Supak Jenkitkasemwong, Shintaro Hojyo, Ramana V. Davuluri, Mitchell D. Knutson, Toshiyuki Fukada, Swarnali Acharyya

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Patients with metastatic cancer experience a severe loss of skeletal muscle mass and function known as cachexia. Cachexia is associated with poor prognosis and accelerated death in patients with cancer, yet its underlying mechanisms remain poorly understood. Here, we identify the metal-ion transporter ZRT- and IRT-like protein 14 (ZIP14) as a critical mediator of cancer-induced cachexia. ZIP14 is upregulated in cachectic muscles of mice and in patients with metastatic cancer and can be induced by TNF-α and TGF-β cytokines. Strikingly, germline ablation or muscle-specific depletion of Zip14 markedly reduces muscle atrophy in metastatic cancer models. We find that ZIP14-mediated zinc uptake in muscle progenitor cells represses the expression of MyoD and Mef2c and blocks muscle-cell differentiation. Importantly, ZIP14-mediated zinc accumulation in differentiated muscle cells induces myosin heavy chain loss. These results highlight a previously unrecognized role for altered zinc homeostasis in metastatic cancer-induced muscle wasting and implicate ZIP14 as a therapeutic target for its treatment.

Original languageEnglish (US)
Pages (from-to)770-781
Number of pages12
JournalNature Medicine
Volume24
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Cachexia
Muscle
Skeletal Muscle
Up-Regulation
Muscle Cells
Zinc
Neoplasms
Proteins
Muscle Neoplasms
Muscles
Muscular Atrophy
Myosin Heavy Chains
Cell Differentiation
Homeostasis
Stem Cells
Metals
Ions
Cytokines
Ablation
Metal ions

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Wang, G., Biswas, A. K., Ma, W., Kandpal, M., Coker, C., Grandgenett, P. M., ... Acharyya, S. (2018). Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nature Medicine, 24(6), 770-781. https://doi.org/10.1038/s41591-018-0054-2

Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. / Wang, Gang; Biswas, Anup K.; Ma, Wanchao; Kandpal, Manoj; Coker, Courtney; Grandgenett, Paul M.; Hollingsworth, Michael A; Jain, Rinku; Tanji, Kurenai; López-Pintado, Sara; Borczuk, Alain; Hebert, Doreen; Jenkitkasemwong, Supak; Hojyo, Shintaro; Davuluri, Ramana V.; Knutson, Mitchell D.; Fukada, Toshiyuki; Acharyya, Swarnali.

In: Nature Medicine, Vol. 24, No. 6, 01.06.2018, p. 770-781.

Research output: Contribution to journalArticle

Wang, G, Biswas, AK, Ma, W, Kandpal, M, Coker, C, Grandgenett, PM, Hollingsworth, MA, Jain, R, Tanji, K, López-Pintado, S, Borczuk, A, Hebert, D, Jenkitkasemwong, S, Hojyo, S, Davuluri, RV, Knutson, MD, Fukada, T & Acharyya, S 2018, 'Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle', Nature Medicine, vol. 24, no. 6, pp. 770-781. https://doi.org/10.1038/s41591-018-0054-2
Wang G, Biswas AK, Ma W, Kandpal M, Coker C, Grandgenett PM et al. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nature Medicine. 2018 Jun 1;24(6):770-781. https://doi.org/10.1038/s41591-018-0054-2
Wang, Gang ; Biswas, Anup K. ; Ma, Wanchao ; Kandpal, Manoj ; Coker, Courtney ; Grandgenett, Paul M. ; Hollingsworth, Michael A ; Jain, Rinku ; Tanji, Kurenai ; López-Pintado, Sara ; Borczuk, Alain ; Hebert, Doreen ; Jenkitkasemwong, Supak ; Hojyo, Shintaro ; Davuluri, Ramana V. ; Knutson, Mitchell D. ; Fukada, Toshiyuki ; Acharyya, Swarnali. / Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. In: Nature Medicine. 2018 ; Vol. 24, No. 6. pp. 770-781.
@article{4cffbf7f647c4d308108fb68f121fbbe,
title = "Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle",
abstract = "Patients with metastatic cancer experience a severe loss of skeletal muscle mass and function known as cachexia. Cachexia is associated with poor prognosis and accelerated death in patients with cancer, yet its underlying mechanisms remain poorly understood. Here, we identify the metal-ion transporter ZRT- and IRT-like protein 14 (ZIP14) as a critical mediator of cancer-induced cachexia. ZIP14 is upregulated in cachectic muscles of mice and in patients with metastatic cancer and can be induced by TNF-α and TGF-β cytokines. Strikingly, germline ablation or muscle-specific depletion of Zip14 markedly reduces muscle atrophy in metastatic cancer models. We find that ZIP14-mediated zinc uptake in muscle progenitor cells represses the expression of MyoD and Mef2c and blocks muscle-cell differentiation. Importantly, ZIP14-mediated zinc accumulation in differentiated muscle cells induces myosin heavy chain loss. These results highlight a previously unrecognized role for altered zinc homeostasis in metastatic cancer-induced muscle wasting and implicate ZIP14 as a therapeutic target for its treatment.",
author = "Gang Wang and Biswas, {Anup K.} and Wanchao Ma and Manoj Kandpal and Courtney Coker and Grandgenett, {Paul M.} and Hollingsworth, {Michael A} and Rinku Jain and Kurenai Tanji and Sara L{\'o}pez-Pintado and Alain Borczuk and Doreen Hebert and Supak Jenkitkasemwong and Shintaro Hojyo and Davuluri, {Ramana V.} and Knutson, {Mitchell D.} and Toshiyuki Fukada and Swarnali Acharyya",
year = "2018",
month = "6",
day = "1",
doi = "10.1038/s41591-018-0054-2",
language = "English (US)",
volume = "24",
pages = "770--781",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle

AU - Wang, Gang

AU - Biswas, Anup K.

AU - Ma, Wanchao

AU - Kandpal, Manoj

AU - Coker, Courtney

AU - Grandgenett, Paul M.

AU - Hollingsworth, Michael A

AU - Jain, Rinku

AU - Tanji, Kurenai

AU - López-Pintado, Sara

AU - Borczuk, Alain

AU - Hebert, Doreen

AU - Jenkitkasemwong, Supak

AU - Hojyo, Shintaro

AU - Davuluri, Ramana V.

AU - Knutson, Mitchell D.

AU - Fukada, Toshiyuki

AU - Acharyya, Swarnali

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Patients with metastatic cancer experience a severe loss of skeletal muscle mass and function known as cachexia. Cachexia is associated with poor prognosis and accelerated death in patients with cancer, yet its underlying mechanisms remain poorly understood. Here, we identify the metal-ion transporter ZRT- and IRT-like protein 14 (ZIP14) as a critical mediator of cancer-induced cachexia. ZIP14 is upregulated in cachectic muscles of mice and in patients with metastatic cancer and can be induced by TNF-α and TGF-β cytokines. Strikingly, germline ablation or muscle-specific depletion of Zip14 markedly reduces muscle atrophy in metastatic cancer models. We find that ZIP14-mediated zinc uptake in muscle progenitor cells represses the expression of MyoD and Mef2c and blocks muscle-cell differentiation. Importantly, ZIP14-mediated zinc accumulation in differentiated muscle cells induces myosin heavy chain loss. These results highlight a previously unrecognized role for altered zinc homeostasis in metastatic cancer-induced muscle wasting and implicate ZIP14 as a therapeutic target for its treatment.

AB - Patients with metastatic cancer experience a severe loss of skeletal muscle mass and function known as cachexia. Cachexia is associated with poor prognosis and accelerated death in patients with cancer, yet its underlying mechanisms remain poorly understood. Here, we identify the metal-ion transporter ZRT- and IRT-like protein 14 (ZIP14) as a critical mediator of cancer-induced cachexia. ZIP14 is upregulated in cachectic muscles of mice and in patients with metastatic cancer and can be induced by TNF-α and TGF-β cytokines. Strikingly, germline ablation or muscle-specific depletion of Zip14 markedly reduces muscle atrophy in metastatic cancer models. We find that ZIP14-mediated zinc uptake in muscle progenitor cells represses the expression of MyoD and Mef2c and blocks muscle-cell differentiation. Importantly, ZIP14-mediated zinc accumulation in differentiated muscle cells induces myosin heavy chain loss. These results highlight a previously unrecognized role for altered zinc homeostasis in metastatic cancer-induced muscle wasting and implicate ZIP14 as a therapeutic target for its treatment.

UR - http://www.scopus.com/inward/record.url?scp=85048252521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048252521&partnerID=8YFLogxK

U2 - 10.1038/s41591-018-0054-2

DO - 10.1038/s41591-018-0054-2

M3 - Article

C2 - 29875463

AN - SCOPUS:85048252521

VL - 24

SP - 770

EP - 781

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 6

ER -